Current and historical gross, operating and net profit margins for Mylan (MYL) over the last 10 years. The current net profit margin for Mylan (MYL) as of March 31, 2018 is 6.04%.
||Medical - Generic Drugs
Mylan NV is a pharmaceutical company. The company develops, licenses, manufactures, markets and distributes generic and specialty pharmaceuticals. It operates primarily in the United States, Canada, Europe, the Middle East, Africa, India, Australia, Japan and New Zealand. Mylan NV, formerly known as Mylan Inc., is based in Canonsburg, Pennsylvania.